Aruba Science Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 6, 2026

Mar. 6, 2026

Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.

GlobeNewswire

Mar. 6, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Revive Environmental Announces CEO Transition

GlobeNewswire

Mar. 6, 2026

Quick Custom Intelligence and Maropost Power Real-Time Data at Enterprise Scale

GlobeNewswire

Mar. 6, 2026

Mubite Introduces New Global Trading Platform Integration with Instant Funding Opportunities

GlobeNewswire

Mar. 6, 2026

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Crescent Biopharma Announces Grants of Inducement Awards

GlobeNewswire

Mar. 6, 2026

UPDATE -- ToltIQ Selected by H.I.G. Capital for Firm-Wide Due Diligence Deployment

GlobeNewswire

Mar. 6, 2026

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

GlobeNewswire

Mar. 6, 2026

Wearable Devices Ltd. Announces 1-for-3 Reverse Stock Split

GlobeNewswire

Mar. 6, 2026

CAMP4 to Participate in Upcoming Investor Conferences

GlobeNewswire

Mar. 6, 2026

Galapagos Creates New Subscription Right Plan

GlobeNewswire

Mar. 6, 2026

Galapagos creëert nieuw inschrijvingsrechtenplan

GlobeNewswire

Mar. 6, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Harvard Bioscience Announces Reverse Stock Split

GlobeNewswire

Mar. 6, 2026

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection

GlobeNewswire

Mar. 6, 2026

Letter to Shareholders from CEO Dr. Ryan Saadi

GlobeNewswire